Clinical trial
Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study
NCT00542178 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Action to Control Cardiovascular Risk in Diabetes (ACCORD) Eye Study
- Lead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2003
- Completion date
- December 31, 2009
- Enrollment
- 3,472 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.